The Comprehensive Flow Cytometry Core (CFCC) is directed by Dr. John D. Mountz with assistance of Co-Directors, Drs.Troy Randall and Olaf Kutsch. The goal of the CFCC is to enhance the productivity of the research base of the UAB Rheumatic Disease Core Center (RDCC) through state-of-the-art flow cytometry and cell separation technologies. To accomplish this, the Core provides the equipment, service and expertise necessary for the application of flow cytometry and related technologies to cell analyses and cell purification at a reasonable cost. These services play a key role in studies of disease pathogenesis and identification of potential therapeutic targets, as well as in analysis of determinants of disease susceptibility and drug responsiveness, and pre-clinical testing of potential therapeutic reagents.
Our Specific Aims are: 1 Service. To improve service by continued improvements of our equipment, through enhanced sophistication of our user base, optimal efficiency of sample analysis, rigorous quality control of all operations and maintenance of operator proficiency for technologically challenging applications. 2. Outreach &Education. To provide informal tutorials, formal courses, symposia, and web-based information with the goals of increasing our user base through enhanced awareness of flow cytometry and introducing established users to newer technologies and applications. 3. Development. To develop new applications in response to users'needs and to take full advantage of equipment capabilities, through discussions with users, participation in international flow cytometry meetings, and inclusion of knowledgeable core users on our Advisory Committee. To keep pace with research needs of the RDCC investigators, we have expanded the capacity of the CFCC and introduced new equipment and technologies. Continued development of innovative applications is enhanced by the depth of expertise at UAB and external collaborations. Education is accomplished through bi-weekly Individualized Design of Experiments &Analyses Sessions (IDEAs) in which the Director/Co-Directors interact with investigators to develop protocols and applications, including integration of flow cytometry aspects in the experimental design with other Cores, including AIIC and AGTC.

Public Health Relevance

The Comprehensive Flow Cytometry Core provides instrumentation and expertise to support fundamental mechanistic studies of rheumatic diseases and autoimmunity. Furthermore, the CFCC resources support the identification of new biomarkers for disease diagnosis and the development of novel treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
2P30AR048311-11
Application #
8444040
Study Section
Special Emphasis Panel (ZAR1-KM (M1))
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
11
Fiscal Year
2012
Total Cost
$177,537
Indirect Cost
$56,351
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Yang, Zhengrong; Hildebrandt, Ellen; Jiang, Fan et al. (2018) Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1. Biochim Biophys Acta Biomembr 1860:1193-1204
Smith, Samuel R; Schaaf, Kaitlyn; Rajabalee, Nusrah et al. (2018) The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Sci Rep 8:902
Chen, Wei; Zhu, Guochun; Jules, Joel et al. (2018) Monocyte-Specific Knockout of C/ebp? Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebp? in Osteoclast Differentiation and Function. J Bone Miner Res 33:691-703
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118
Jo, SeongHo; Chen, Junqin; Xu, Guanlan et al. (2018) miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function. Diabetes 67:256-264
Stafman, Laura L; Williams, Adele P; Garner, Evan F et al. (2018) Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma. Transl Oncol 12:200-208
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Yang, Zhenhua; Shah, Kushani; Busby, Theodore et al. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. J Clin Invest 128:3605-3618

Showing the most recent 10 out of 340 publications